IL2 and neoplasm: In multiple in vitro and murine tumor models, PD1/PDL1 blockade in combination with an agonist CD27 monoclonal antibody was shown to enhance CD8+ cytotoxic T-cell expansion and function in an IL-2 dependent manner with gene expression changes promoting T-cell proliferation (66).